Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein

Abstract Treatment of antibiotic-resistant infections is dependent on the detection of specific bacterial genes or proteins in clinical assays. Identification of methicillin-resistant Staphylococcus aureus (MRSA) is often accomplished through the detection of penicillin-binding protein 2a (PBP2a). W...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jason R. Neil, Arvind Verma, Scott R. Kronewitter, William M. McGee, Christopher Mullen, Marjaana Viirtola, Annika Kotovuori, Herdis Friedrich, Johan Finell, Joni Rannisto, John E. P. Syka, James L. Stephenson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/0dfbf32c8a3946799273c05df9f0788a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0dfbf32c8a3946799273c05df9f0788a
record_format dspace
spelling oai:doaj.org-article:0dfbf32c8a3946799273c05df9f0788a2021-12-02T18:50:48ZRapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein10.1038/s41598-021-97844-w2045-2322https://doaj.org/article/0dfbf32c8a3946799273c05df9f0788a2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97844-whttps://doaj.org/toc/2045-2322Abstract Treatment of antibiotic-resistant infections is dependent on the detection of specific bacterial genes or proteins in clinical assays. Identification of methicillin-resistant Staphylococcus aureus (MRSA) is often accomplished through the detection of penicillin-binding protein 2a (PBP2a). With greater dependence on mass spectrometry (MS)-based bacterial identification, complementary efforts to detect resistance have been hindered by the complexity of those proteins responsible. Initial characterization of PBP2a indicates the presence of glycan modifications. To simplify detection, we demonstrate a proof-of-concept tandem MS approach involving the generation of N-terminal PBP2a peptide-like fragments and detection of unique product ions during top-down proteomic sample analyses. This approach was implemented for two PBP2a variants, PBP2amecA and PBP2amecC, and was accurate across a representative panel of MRSA strains with different genetic backgrounds. Additionally, PBP2amecA was successfully detected from clinical isolates using a five-minute liquid chromatographic separation and implementation of this MS detection strategy. Our results highlight the capability of direct MS-based resistance marker detection and potential advantages for implementing these approaches in clinical diagnostics.Jason R. NeilArvind VermaScott R. KronewitterWilliam M. McGeeChristopher MullenMarjaana ViirtolaAnnika KotovuoriHerdis FriedrichJohan FinellJoni RannistoJohn E. P. SykaJames L. StephensonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jason R. Neil
Arvind Verma
Scott R. Kronewitter
William M. McGee
Christopher Mullen
Marjaana Viirtola
Annika Kotovuori
Herdis Friedrich
Johan Finell
Joni Rannisto
John E. P. Syka
James L. Stephenson
Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein
description Abstract Treatment of antibiotic-resistant infections is dependent on the detection of specific bacterial genes or proteins in clinical assays. Identification of methicillin-resistant Staphylococcus aureus (MRSA) is often accomplished through the detection of penicillin-binding protein 2a (PBP2a). With greater dependence on mass spectrometry (MS)-based bacterial identification, complementary efforts to detect resistance have been hindered by the complexity of those proteins responsible. Initial characterization of PBP2a indicates the presence of glycan modifications. To simplify detection, we demonstrate a proof-of-concept tandem MS approach involving the generation of N-terminal PBP2a peptide-like fragments and detection of unique product ions during top-down proteomic sample analyses. This approach was implemented for two PBP2a variants, PBP2amecA and PBP2amecC, and was accurate across a representative panel of MRSA strains with different genetic backgrounds. Additionally, PBP2amecA was successfully detected from clinical isolates using a five-minute liquid chromatographic separation and implementation of this MS detection strategy. Our results highlight the capability of direct MS-based resistance marker detection and potential advantages for implementing these approaches in clinical diagnostics.
format article
author Jason R. Neil
Arvind Verma
Scott R. Kronewitter
William M. McGee
Christopher Mullen
Marjaana Viirtola
Annika Kotovuori
Herdis Friedrich
Johan Finell
Joni Rannisto
John E. P. Syka
James L. Stephenson
author_facet Jason R. Neil
Arvind Verma
Scott R. Kronewitter
William M. McGee
Christopher Mullen
Marjaana Viirtola
Annika Kotovuori
Herdis Friedrich
Johan Finell
Joni Rannisto
John E. P. Syka
James L. Stephenson
author_sort Jason R. Neil
title Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein
title_short Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein
title_full Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein
title_fullStr Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein
title_full_unstemmed Rapid MRSA detection via tandem mass spectrometry of the intact 80 kDa PBP2a resistance protein
title_sort rapid mrsa detection via tandem mass spectrometry of the intact 80 kda pbp2a resistance protein
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/0dfbf32c8a3946799273c05df9f0788a
work_keys_str_mv AT jasonrneil rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT arvindverma rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT scottrkronewitter rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT williammmcgee rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT christophermullen rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT marjaanaviirtola rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT annikakotovuori rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT herdisfriedrich rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT johanfinell rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT jonirannisto rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT johnepsyka rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
AT jameslstephenson rapidmrsadetectionviatandemmassspectrometryoftheintact80kdapbp2aresistanceprotein
_version_ 1718377485921419264